Pazopanib in pretreated advanced neuroendocrine tumors: A phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)

  1. Grande, E.
  2. Capdevila, J.
  3. Castellano, D.
  4. Teulé, A.
  5. Durán, I.
  6. Fuster, J.
  7. Sevilla, I.
  8. Escudero, P.
  9. Sastre, J.
  10. García-Donas, J.
  11. Casanovas, O.
  12. Earl, J.
  13. Ortega, L.
  14. Apellaniz-Ruiz, M.
  15. Rodriguez-Antona, C.
  16. Alonso-Gordoa, T.
  17. Díez, J.J.
  18. Carrato, A.
  19. García-Carbonero, R.
Aldizkaria:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Argitalpen urtea: 2015

Alea: 26

Zenbakia: 9

Orrialdeak: 1987-1993

Mota: Artikulua

DOI: 10.1093/ANNONC/MDV252 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus